CROX
Crocs, Inc.
NasdaqGSUSDEQUITY
Consumer Cyclical
DELAYED
Last price
121.45
▼ 1.64 (1.33%)
MARKET · —
Price
Open
122.28
Prev close
123.09
Day high
124.41
Day low
121.99
Volume
773.50K
Market cap
$5.85B
P/E (TTM)
10.83
52W range
73.21 – 141.28
Trailing performance
Returnvs SPY
1W
-7.30%
-5.9%
1M
-7.82%
-11.6%
3M
+12.10%
+9.0%
6M
+22.06%
+11.0%
YTD
+42.79%
+30.5%
1Y
+45.86%
+25.9%
3Y
+29.89%
-44.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$5.85B
Enterprise value$7.37B
Revenue (TTM)$4.05B
Gross profit$2.33B
EBITDA$926.54M
Net income$593.42M
EPS (TTM)$11.27
Free cash flow$533.89M
Total cash$170.28M
Total debt$1.69B
Book value / share$28.77
Shares outstanding47.95M
Float46.12M
Short % of float12.41%
Dividend yield—
Beta (5Y)1.53
Valuation & profitability ratios
Trailing P/E10.83
Forward P/E8.17
PEG ratio1.39
Price / sales—
Price / book4.24
EV / revenue1.82
EV / EBITDA7.96
Gross margin57.47%
Operating margin24.22%
Profit margin14.64%
Return on equity42.30%
Return on assets11.99%
Debt / equity121.99
Current ratio1.49
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | $4.04B | $4.10B | $3.96B | $3.55B |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| R&D | — | — | — | — |
| SG&A | — | — | — | — |
| Operating income | — | — | — | — |
| Pre-tax income | — | — | — | — |
| Tax provision | $0 | $0 | $0 | $0 |
| Net income | -$81.20M | $950.07M | $792.57M | $540.16M |
| EBIT | $0 | $0 | $0 | $0 |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Cash & equivalents | — | — | — | — |
| Short-term investments | — | — | — | — |
| Net receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Total current assets | — | — | — | — |
| Total assets | — | — | — | — |
| Total current liabilities | — | — | — | — |
| Long-term debt | — | — | — | — |
| Total liabilities | — | — | — | — |
| Retained earnings | — | — | — | — |
| Shareholder equity | — | — | — | — |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$81.20M | $950.07M | $792.57M | $540.16M |
| Depreciation | — | — | — | — |
| Change in working capital | — | — | — | — |
| Operating cash flow | — | — | — | — |
| Capital expenditure | — | — | — | — |
| Investing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Buybacks | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Net change in cash | — | — | — | — |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 4.35 | 4.55 | +4.7% |
| Mar 2026 | 2.79 | 2.99 | +7.2% |
| Dec 2025 | 1.91 | 2.29 | +19.7% |
| Sep 2025 | 2.36 | 2.92 | +23.7% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 3.30 | 14 | $1.00B | +0.7% |
| Next quarter | 3.11 | 13 | $995.71M | +4.0% |
| Current year | 13.95 | 15 | $4.10B | +1.5% |
| Next year | 14.95 | 15 | $4.20B | +2.5% |
Analyst targets & ownership
Mean target$138.25
High target$163.00
Low target$95.00
Implied upside13.83%
Analyst count12
ConsensusBUY
Strong buy / Buy2 / 5
Hold7
Sell / Strong sell1 / 0
Held by insiders3.09%
Held by institutions103.59%
Institutions holding650
Price targets, consensus spread, insider and institutional ownership.
Insider net activity
Net shares
+539.30K
Net buying
Buy transactions
15
619.09K shares
Sell transactions
4
79.80K shares
Net transactions
+19
Buys less sells
Sell : buy shares
0.1 : 1
Mixed
Insider-held shares
1.48M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 10, 26 | REES ANDREW VIVIAN Chief Executive Officer |
SELL | 30.00K | $4.15M | Indirect |
| Aug 4, 26 | REES ANDREW VIVIAN Chief Executive Officer |
CONVERSION | 200.00K | $1.40M | Direct |
| Jun 9, 26 | HUGHES CHARISSE FORD Director |
STOCK | 1.25K | $0 | Direct |
| Jun 9, 26 | TOLMARE NEERAJ Director |
STOCK | 2.35K | $0 | Direct |
| Jun 9, 26 | BICKLEY IAN M Director |
STOCK | 1.25K | $0 | Direct |
| Jun 9, 26 | REPLOGLE JOHN B Director |
STOCK | 1.25K | $0 | Direct |
| Jun 9, 26 | SMACH THOMAS J Director |
STOCK | 4.11K | $0 | |
| Jun 9, 26 | TREFF DOUGLAS J Director |
STOCK | 2.54K | $0 | Direct |
| Jun 9, 26 | KAPLAN BETH JANELL Director |
STOCK | 1.25K | $0 | Direct |
| Jun 9, 26 | FRASCH RONALD L Director |
STOCK | 1.25K | $0 | Direct |
| Jun 5, 26 | REES ANDREW VIVIAN Chief Executive Officer |
SELL | 32.69K | $3.86M | Indirect |
| May 22, 26 | FRASCH RONALD L Director |
STOCK | 500 | $0 | Direct |
| Mar 10, 26 | MEHLMAN ANNE Officer |
STOCK | 68.34K | $0 | Direct |
| Mar 10, 26 | REILLY TERENCE Officer |
STOCK | 44.22K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
CAMPBELL RUPERT GEORGE |
Officer | 71.22K | Stock Award(Grant) |
FRASCH RONALD L |
Director | 76.18K | Stock Award(Grant) |
HEALY SUSAN L |
Chief Financial Officer | 50.08K | Purchase |
MEHLMAN ANNE |
Officer | 185.21K | Stock Award(Grant) |
MICHAELS ADAM |
Officer | 89.32K | Sale |
REAGAN PATRAIC |
Chief Financial Officer | 89.59K | Stock Award(Grant) |
REES ANDREW VIVIAN |
Chief Executive Officer | — | Sale |
REILLY TERENCE |
Officer | 112.35K | Stock Award(Grant) |
SMACH THOMAS J |
Director | — | Stock Award(Grant) |
TREFF DOUGLAS J |
Director | 86.89K | Stock Award(Grant) |
Moving averages & technicals
SMA 10
129.44
-6.17% from price
SMA 20
131.71
-7.29% from price
SMA 50
129.48
-5.69% from price
SMA 100
117.19
+3.63% from price
SMA 200
101.12
+20.76% from price
EMA 12
128.76
-5.68% from price
EMA 26
130.06
-6.62% from price
EMA 50
127.18
-4.51% from price
RSI (14)
38.6
Neutral
MACD (12,26,9)
-1.29
Hist -1.71
ATR (14)
4.73
3.87% of price
Realised vol 30D
42.5%
Annualised
Bollinger upper
141.99
20, 2σ
Bollinger lower
121.44
20, 2σ
50 / 200 cross
Golden
129.48 vs 101.12
Trend bias
Above 200
+20.76%
Risk profile
Beta vs SPY
0.87
Less volatile than market
Correlation to SPY
0.25
Largely independent
Realised vol 30D
42.5%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-24.3%
Peak to trough
Max drawdown 5Y
-73.9%
Peak to trough
ATR 14
4.73
3.87% of price
Beta (reported)
1.53
5Y monthly, from filing
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
1.08
Put-heavy session
Put / call open interest
1.07
Positioning, not flow
Max pain
130.00
+6.5% from spot
ATM implied vol
52.3%
Nearest strike to spot
Skew (10% OTM)
-0.7%
Calls bid over puts
Call volume
252
Contracts, this expiry
Put volume
272
Contracts, this expiry
Heaviest call OI
135.00
2.27K contracts
Heaviest put OI
135.00
2.70K contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
Ralph Lauren Trades at Premium Valuation: Should Investors Buy?
Zacks · 2d ago
Crocs Raises 2026 Outlook: Is the Growth Story Strengthening?
Zacks · 3d ago
VF Corp. Raises Fiscal 2027 Sales Outlook as Outdoor Growth Offsets Vans
Zacks · 4d ago
Is VFC Worth Buying as Cheap Valuation Meets Vans Execution Risk?
Zacks · 4d ago
Amer Sports Shares Up After Strong 2Q Performance, Raises 2026 Guidance
Exec Edge · 4d ago
Popular shoe retailer closing dozens of stores after a costly mistake
TheStreet · 4d ago
Crocs (CROX) Could Be 140% Undervalued Even After CEO Share Sale
Simply Wall St. · 5d ago
Crocs CEO Andrew Rees Sells 30,000 Shares for $4.2 Million -- Do Investors Need to Take Notice?
Motley Fool · 6d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.